|
Volumn 141, Issue 7, 2006, Pages 239-240
|
Clinical relevance of interactions between QT-interval prolonging drugs is easy to estimate per patient;Klinische relevantie QT-interacties goed in te schatten per patiënt: Wegklikken, net als bij windows
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
ANTIBIOTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
DIURETIC AGENT;
SOTALOL;
ANGINA PECTORIS;
ARTICLE;
DRUG EFFECT;
ELECTROCARDIOGRAM;
HEART ARRHYTHMIA;
HUMAN;
HYPOKALEMIA;
MEDICAL INFORMATION SYSTEM;
PATIENT SELECTION;
PUBLICATION;
QT PROLONGATION;
RISK ASSESSMENT;
SIDE EFFECT;
|
EID: 33644646203
PISSN: 00316911
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|